Trial intelligence / Profile preview

Doripenem PK/PD in Febrile Neutropenia

NCT01401010Phase 4Completed

Sponsor
Gary E. Stein
Start
Aug 2010
Primary completion
Feb 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of doripenem in febrile neutropenia (FN), sponsored by Gary E. Stein. Started Aug 2010; status: completed.

02

Drugs

doripenem
03

Conditions

febrile neutropenia (FN)

Beyond the preview

Go deeper on NCT01401010.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01401010.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call